Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-01-10
1990-08-21
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3702, C07K 1300
Patent
active
049506463
ABSTRACT:
DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human lipocortin-like polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human lipocortin-like polypeptide. In appropriate hosts these DNA sequences permit the production of human lipocortin-like polypeptides useful as anti-inflammatory agents and methods in the treatment of arthritic, allergic, dermatologic, ophthalmic and collagen diseases as well as other disorders involving inflammatory processes.
REFERENCES:
patent: 4239780 (1980-12-01), Wallach
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4530901 (1985-07-01), Weissmann
patent: 4537858 (1985-08-01), O'Sullivan et al.
patent: 4874743 (1989-10-01), Wallner
patent: 4879224 (1989-11-01), Wallner
F. F. Davidson et al., "Inhibition of Phospholipase A.sub.2 by `Lipocortins` and Calpactins", J. Biol. Chem., 262, pp. 1698-1705 (1987).
G. J. Blackwell et al., "Glucocorticoids Induce the Formation and Release of Anti-Inflammatory and Anti-Phospholipase Proteins into the Peritoneal Cavity of the Rat", Br. J. Pharmac., 76, pp. 185-194 (1982).
P. Diamond, "Biogen Produces Recombinant Anti-Inflammatory Agent", Genetic Engineering News, 5, p. 12 (1985).
M. DiRosa et al., "Anti-Phospholipase Proteins", Prostaglandins, 28, pp. 441-442 (1984).
E. Erikson et al., "Identification of a Cellular Protein Substrate Phosphorylated by the Avian Sarcoma Virus Transforming Gene Product", Cell, 21, pp. 829-836 (1980).
E. Erikson et al., "Biochemical Characterization of a 34 Kilodalton Normal Cellular Substrate of pp60 and an Associated 6-Kilodalton Protein", Mol. Gen. Biol., 4, pp. 77-85 (1984).
M. Errasfa et al., "The Presence of Lipocortin in Human Embryonic Skin Fibroblasts and its Regulation by Anti-Inflammatory Steroids", Biochemica et Biophysica Acta, 847, pp. 247-254 (1985).
J. Etiene and J. Polonovski, "Phospholopase A.sub.2 Activity in Rat and Human Lymphocytes", Biochem. and Biophys. Res. Comm., 125, pp. 719-727 (1984).
R. Fava and S. Cohen, "Isolation of a Calcium-Dependent 35 Kilodalton Substrate for the Epidermal Growth Factor Receptor/Kinase from A-431 Cells", J. Biol. Chem., 259, pp. 2636-2645 (1984).
R. J. Flower and G. J. Blackwell, "Anti-Inflammatory Steriods Induce Biosynthesis of a Phospholipase A.sub.2 Inhibitor which Prevents Prostaglandin Generation", Nature, 278, pp. 456-459 (1979).
R. J. Flower et al., "Macrocortin and the Mechanism of Action of the Glucocorticoids", Advances in Inflammation Research, 7, pp. 61-70 (1984).
M. J. Geisow, "Common Domain Structure of Ca and Lipid Binding Proteins", FEBS Letters, 92, pp. 99-103 (1986).
M. J. Geisow and J. H. Walker, "New Proteins Involved in Cell Regulation by Ca and Phospholipids", Trends Biochem. Sci., 11, pp. 420-423 (1986).
V. Gerke and K. Weber, "Identity of p36K Phosphorylated Upon Rous Sarcoma Virus Transformation with a Protein Purified from Brush Borders; Calcium-Dependent Binding to Non-Erythoid Spectrin and F-Actin", EMBO Journal, 3, pp. 227-233 (1984).
V. Gerke and K. Weber, "Calcium-Dependent Conformational Changes in the 36-kDa Subunit of Intestinal Protein I Related to the Cellular 36-kDa Target of Rous Sarcoma Virus Tyrosine Kinase", J. Biol. Chem., 260, pp. 1688-1695 (1985).
J. R. Glenney and B. F. Tack, "Amino-Terminal Sequence of p36 and Associated p10: Identification of the Site of Tyrosine Phosphorylation and Homology with S-100", Proc. Nat. Acad. Sci. U.S.A., 82, pp. 7884-7888 (1985).
T. Hattori et al., "Inhibition of Human Natural Killer (NK) Activity and Antibody Dependent Cellular Cytotoxicity (ADCC) by Lipomodulin, a Phospholipase Inhibitory Protein", J. Immunol., 131, pp. 662-665 (1983).
F. Hirata, "The Regulation of Lipomudulin, a Phospholipase Inhibitory Protein in Rabbit Neutrophils by Phosphorylation", J. Biol. Chem., 256, pp. 7730-7733 (1981).
Hirata et al., "Presence of Autoantibody for Phospholipase Inhibitory Protein, Lipomudulin in Patients with Rheumatic Disease", Proc. Nat. Acad. Sci. U.S.A., 78, pp. 3190-3194 (1981).
F. Hirata, "Roses of Lipmodulin: A Phospholipase Inhibitory Protein in Immunoregulation", Adv. Inflm. Res., 7, pp. 71-78 (1984).
F. Hirata et al., "Inhibition of Leukocyte Chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly", Biochemn. and Biophys. Res. Comm., 118, pp. 682-690 (1984).
F. Hirata et al., "Isolation and Characterizaiton of Lipocortin (Lipomodulin)", Agents and Actions, 17, pp. 263-266 (1985).
K. Huang et al., "Two Human 35 Kd Inhibitors of Phospholipase A.sub.2 are Realted to Substrates of pp60 and of the Epidermal Growth Factory Receptor/Kinas", Cell, 46, pp. 191-199 (1986).
R. H. Kretsinger et al., "Consensus in Exocytosis", Nature, 320, p. 573 (1986).
I. Mancheva et al., "The Primary Structure of the Inhibitor of Vipoxin from the Vernom of the Bulgarian Viper (Vipera Ammodytes, Serpentes)", Hoppe-Selye's Z. Physiol. Chem., 365, pp. 885-894 (1984).
I. Mancheva et al., "Sequence Homology Between Phospholipase and its Inhibitor in Snake Vernom: The Primary Structure of the Inhibitor of Vipoxin from the Vernom of the Bulgarian Viper", Biol. Abstr., 79, #39874 (1984).
T. Maniatis et al., "Molecular Cloning (A Laboratory Manual), "pp. 5-6, 405-514 (1984).
J. F. Morrow, "Recombinant DNA Techniques", Methods in Enzymology, 68, pp. 3-24 (1979).
Oroszylan et al., "Amino-and Carboxyl-Terminal Amino Acid Sequences of Proteins Coded by gag Gene of Murine Leukemia Virus", Proc. Nat. Acad. Sci. U.S.A., 75, pp. 1404-1408 (1977).
R. B. Pepinsky et al., "Localization of Lipid-Protein and Protein-Protein Interactions within the Murine gag Precursor by a Novel Peptide-Mapping Technique", J. Biol. Chem., 258, pp. 11229-11235 (1983).
R. B. Pepinsky and L. K. Sinclair, "Epidermal Growth Factor-Dependent Phosphoylation of Lipcortin", Nature, 321, pp. 81-84 (1986).
R. B. Pepinsky et al., "Purification and Partial Sequence Analysis of a 37-kDa Protein that Inhibits Phospholipase A.sub.2 Activity from Rat Peritoneal Exudates", J. Biol. Chem., 261, pp. 4239-4246 (1986).
K. Radke et al., "Transformation by Rous Sarcoma Virus: A Cellular Substrate for Transformation-Specific Protein Phosphorylation Contains Phosphotyrosine", Cell, 21, pp. 821-828 (1980).
C. J. M. Saris et al., "The cDNA Sequence for the Protein-Tyrosine Kinase Substrate p36 (Calpactin I Heavy Chain) Reveals a Multidomain Protein with Internal Repeats", Cell, 46, pp. 201-212 (1986).
B. P. Wallner et al., "Cloning and Expression of Human Lipocortin, A Phospholipase A.sub.2 Inhibitor with Potential Anti-Inflammatory Activity", Nature, 320, pp. 77-81 (1986).
"Biogen Produces Anti-Inflammatory Agent; Davies Resigns", Genetic Engineering Letter, p. 4, Jun. 10, 1985.
Proc. Nat'l. Acad. Sci., 82 (1985), 7884-7888.
Cell., vol. 46, 191-199 (1986).
Chem. Abstr., vol. 100, (1984), 119189.
Chem. Abstr., vol. 99, (1983), 86478.
Garwin Jeffrey L.
Huang Kuo-Sen
Pepinsky R. Blake
Schindler Daniel G.
Wallner Barbara P.
Biogen Inc.
Haley, Jr. James F.
Lee Lester L.
Loring Denise L.
Meyer David J.
LandOfFree
DNA sequences, recombinant DNA molecules and processes for produ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA sequences, recombinant DNA molecules and processes for produ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA sequences, recombinant DNA molecules and processes for produ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1677658